Feedback / Questions
lirentelimab (AK002) - Allakos
http://clinicaltrials.gov/ct2/show/NCT02808793
Jun 22, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev